ArticleMolecular and clinical oncology2019

Early blood rise in auto-antibodies to nuclear and smooth muscle antigens is predictive of prolonged survival and autoimmunity in metastatic-non-small cell lung cancer patients treated with PD-1 immune-check point blockade by nivolumab.

Rocco Giannicola et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.